Veru Inc. (VERU) — Earnings Call X-Ray
Our AI read all 29 of VERU's earnings calls (2018–2025) and answered the same battery of questions about each one. Every past call is free; the newest quarter unlocks with a free account.
Previous Call Grade
C+
Q1 2025
Calls Analyzed
29
2018–2025
Avg Candor
6.3/9
evasion 2.7/9
Call-by-call analysis
🔒 Q2 2025 earnings call
2025-05-08
NEWEST
Guidance: ■■■■■Demand: ■■■■■■
Margins: ■■■■Backlog: ■■■■
■ analysts, ■■ questionsexpected move ±■■%
Management ■■■■■■ guidance against ■■■■■■■■ demand and ■■■■■■■ margins. The delivery was ■■■■■■■■ and ■■■■ in specifics, with ■■■ questions left hanging.
🔒 The Q2 2025 call grade is ready
The full 37-point AI read of VERU's newest earnings call — grade, expected move, and every question answered — is free with an account.
Sign up free to unlock
C+
Q1 2025 earnings call
2025-02-13
Management gave no formal guidance. The delivery was unusually candid, rich in specifics, promotional in tone.
Headcount: flat 4 analysts · 10 questions
⚑ Critic ammunition⚑ Question left hanging✓ Resolves doubts⚑ Reads rehearsedDirection beats results
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?
D
Q3 2024 earnings call
2024-08-10
Management gave no formal guidance against steady demand and contracting margins. The delivery was rich in specifics, promotional in tone.
Demand: stableMargins: contractingPricing: stableHeadcount: cutting 5 analysts · 8 questions
⚑ Critic ammunition⚑ Question left hanging⚑ Reads rehearsedDirection beats results
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
NO Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
YES Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?
D
Q1 2024 earnings call
2024-05-08
move ±28.9%
Management gave no formal guidance against contracting margins. The delivery was rich in specifics, promotional in tone.
Margins: contractingHeadcount: cutting 4 analysts · 7 questions
⚑ Critic ammunition⚑ Question left hanging⚑ Reads rehearsedDirection beats results
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
NO Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?
D
Q1 2024 earnings call
2024-02-08
Management gave no formal guidance against expanding margins. The delivery was rich in specifics, promotional in tone.
Margins: expandingPricing: stable 3 analysts · 6 questions
⚑ Critic ammunition⚑ Question left hanging⚑ Reads rehearsedFounder-ledDirection beats results
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
NO Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
YES Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
YES Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?
D
Q2 2023 earnings call
2023-08-10
move ±12.9%
Management held guidance steady against mixed demand signals and contracting margins. The delivery was unusually candid, rich in specifics, promotional in tone.
Guidance: maintainedDemand: mixedMargins: contractingBacklog: growingPricing: stable 3 analysts · 5 questions
⚑ Critic ammunition⚑ Question left hanging✓ Volume step-up ahead✓ Early product, fast growthFounder-ledHidden segment
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
NO Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
YES Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
YES Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
YES Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
YES Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
YES Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?
D
Q1 2023 earnings call
2023-05-11
move ±22.6%
Management gave no formal guidance against slowing demand and contracting margins. The delivery was unusually candid, rich in specifics, promotional in tone.
Demand: slowingMargins: contractingPricing: under pressureHeadcount: cuttingCapex: decreasing 3 analysts · 4 questions
⚑ Critic ammunition⚑ Question left hangingHidden segmentDirection beats results
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
NO Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
YES Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
YES Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?
F
Q1 2023 earnings call
2023-02-09
move ±17.5%
Management gave no formal guidance against mixed demand signals and contracting margins. The delivery was rich in specifics, promotional in tone.
Demand: mixedMargins: contractingPricing: stableHeadcount: flatCapex: decreasing 3 analysts · 6 questions
⚑ Critic ammunition⚑ Question left hangingDirection beats results
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
NO Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?
Earlier calls
| Call | Date | Grade | Guidance | Demand | Margins | Candor | Evasion |
|---|
| Q4 2022 |
2022-12-05 |
F |
none | slowing | stable |
5/9 |
6/9 |
| Q3 2022 |
2022-08-11 |
D |
none | slowing | contracting |
6/9 |
3/9 |
| Q2 2022 |
2022-05-12 |
D |
none | accelerating | expanding |
6/9 |
3/9 |
| Q1 2022 |
2022-02-09 |
D |
none | stable | expanding |
6/9 |
3/9 |
| Q4 2021 |
2021-12-02 |
D |
raised | accelerating | expanding |
6/9 |
3/9 |
| Q3 2021 |
2021-08-12 |
C+ |
raised | accelerating | expanding |
7/9 |
2/9 |
| Q2 2021 |
2021-05-12 |
C+ |
raised | accelerating | expanding |
6/9 |
2/9 |
| Q1 2021 |
2021-02-10 |
C |
none | accelerating | expanding |
7/9 |
2/9 |
| Q4 2020 |
2020-12-09 |
C |
raised | accelerating | expanding |
6/9 |
3/9 |
| Q3 2020 |
2020-08-13 |
C+ |
raised | accelerating | stable |
6/9 |
2/9 |
| Q2 2020 |
2020-05-13 |
C |
raised | accelerating | expanding |
6/9 |
3/9 |
| Q1 2020 |
2020-02-12 |
D |
maintained | accelerating | contracting |
6/9 |
3/9 |
| Q4 2019 |
2019-12-12 |
C |
maintained | accelerating | stable |
6/9 |
3/9 |
| Q3 2019 |
2019-08-08 |
C+ |
maintained | accelerating | expanding |
7/9 |
3/9 |
| Q1 2019 |
2019-05-16 |
C+ |
raised | accelerating | expanding |
6/9 |
2/9 |
| Q1 2019 |
2019-02-13 |
C |
none | accelerating | expanding |
6/9 |
2/9 |
| Q4 2018 |
2018-12-13 |
C |
raised | accelerating | expanding |
6/9 |
2/9 |
| Q3 2018 |
2018-08-14 |
C |
none | accelerating | expanding |
6/9 |
2/9 |
| Q2 2018 |
2018-05-09 |
C |
maintained | mixed | contracting |
6/9 |
2/9 |
| Q1 2018 |
2018-02-14 |
C |
none | mixed | stable |
7/9 |
2/9 |
| Q4 2017 |
2018-01-05 |
D |
none | mixed | contracting |
6/9 |
3/9 |
Research question bank — earlier calls
During our 1,600-question research program, batches of experimental hypotheses were tested directly against some of VERU's earlier calls. The YES answers — the rare hits — are shown; click any question to see every company that matched it. Full list: the question bank.
D
Q4 2017 earnings call
2018-01-05
2 more research questions answered NO
How to read this page
The grade is a transparent composite of call quality — candor, specificity, low evasion, low stress, whether the call resolves more doubts than it creates, and the guidance action — not a buy or sell signal. The expected move is a volatility estimate from the one signal that survived our out-of-sample tests: how a stock's own reaction and pre-call volatility predict the size (not direction) of its next move. Full detail, including everything that failed: methodology.
Companies with similar call quality
← VERO All “V” companies
VERX →
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our
methodology.